Guangxi Yi Bao Co. Ltd is a specialized supplier of Levodopa since 1983. With more than two decades’ experiences, it has become an influential enterprise for medicines and health products in Guangxi, China.
Kindly be informed that LEVODOPA --is the first selected medicine used in treatment of Parkinson’s disease. Guangxi is an only origin in China where LEVODOPA is produced. Annual output of Levodopa reach 50 ton, its quality conforms to USP/BP/EP Standard.
If LEVODOPA is one of ingredients of your product and of interest to you, please let us know. We shall be glad to give you the sample with COA and our lowest quotation upon receipt of your detailed requirement.
BR.TradeHolding.com Tip: We always strongly recommend our members to strictly follow the traditional methods and rules of international trading before going into any deal with any party met over the internet. Such as getting prior company confirmation by phone, fax or by mail besides necessary cross checks done through the related local bodies like banks, chambers of commerce, related trade associations, etc. especially before realizing any money transaction.
Statistics: Companies: 641,700+, Trade Leads: 160,400+, Products: 104,200+, Contacts / Replies: 8,281,800+ There are currently 23778 users online browsing our B2B network. 8:28 GMT, Friday, September 20, 2024 Privacy Policy Important Notice! TradeHolding.com B2B Network does not provide an escrow service! Any member who asks you to pay for their products by Western Union to an agent of "TradeHolding.com B2B Network" is fraud and should be immediately reported to us. Do not pay anything to any member who states your money will be added to TradeHolding.com safety deposit account!
All Trade Leads / Offers / Products / Company Profiles / Images and other user-posted contents are posted by the user and BR.TradeHolding.com and TradeHolding.com B2B Network shall not be held liable for any such content. However, TradeHolding.com B2B Network respects the intellectual property, copyright, trademark, trade secret or any other personal or proprietary third party rights and expects the same from others. For concerns, please contact us.